Sohail Ikram, M.D., FACC

Sohail Ikram, M.D. FACC

Sohail Ikram, M.D. FACC

UofL Physicians Outpatient Center
401 East Chestnut Street, Ste. 310
Louisville, KY 40202

502-852-7959- Academic Office
502-588-4600 - Patient Appointments


Clinical Expertise
Invasive and Interventional Cardiology; Endovascular Interventions; Transthoracic, Transesophageal and Stress Echocardiography; Nuclear Cardiology; General Cardiology


Board Certifications

  • American Board of Internal Medicine -
    Cardiovascular Disease / Interventional Cardiology

Education and Training

  • Medical School: Rawalpindi Medical College, Punjab University Pakistan
  • Residency: University of Louisville Hospital
  • Fellowship: Washington Hospital Center (Peripheral Vascular Intervention); University of Louisville (Interventional Cardiology / Cardiovascular Diseases)

Featured Publications

  • Singam NSV, Burkhart T, Ikram S. Anomalous Origin of the Right Coronary Artery from the Left Main Coronary Artery in the Setting of Critical Bicuspid Aortic Valve Stenosis. Methodist Debakey Cardiovasc J. 2019 Jul-Sep;15(3):223-225. doi: 10.14797/mdcj-15-3-223. PubMed PMID: 31687103; PubMed Central PMCID: PMC6822649.
  • Ikram S, Pachika A, Schuster H, Ghotra A, Dotson L, Akbar S, Khan AR. Single-Center Retrospective Study of Risk Factors and Predictive Value of Framingham Risk Score of Patients with ST Elevation Myocardial Infarction. South Med J. 2018 Apr;111(4):226-229. doi: 10.14423/SMJ.0000000000000785. PubMed PMID: 29719035.
  • Tripathi A, Abbott JD, Fonarow GC, Khan AR, Barry NG 4th, Ikram S, Coram R, Mathew V, Kirtane AJ, Nallamothu BK, Hirsch GA, Bhatt DL. Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database Analysis. Circ Cardiovasc Interv. 2017 Dec;10(12). pii: e005925. doi: 10.1161/CIRCINTERVENTIONS.117.005925. PubMed PMID: 29246918.
  • Bhatia N, Sawyer RD, Ikram S. Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario. Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):248-252. doi: 10.14797/mdcj-13-4-248. PubMed PMID: 29744018; PubMed Central PMCID: PMC5935285.
  • Ikram S, Veerappan Kandasamy V. Ticagrelor-induced Sweet Syndrome: an unusual dermatologic complication after percutaneous coronary intervention. Cardiovasc Interv Ther. 2017 Jul;32(3):244-246. doi: 10.1007/s12928-016-0398-9. Epub 2016 May 4. PubMed PMID: 27146134.
  • Khan AR, Bavishi C, Riaz H, Farid TA, Khan S, Atlas M, Hirsch G, Ikram S, Bolli R. Increased Risk of Adverse Neurocognitive Outcomes With Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors. Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). pii: e003153. doi: 10.1161/CIRCOUTCOMES.116.003153. PubMed PMID: 28073851.
  • Ikram S, Saleem N, Latif RK. Acute left ventricle failure on induction of anesthesia: a case report of reverse stress cardiomyopathy-presentation, diagnosis and treatment. J Anesth. 2016 Oct;30(5):911-4. doi: 10.1007/s00540-016-2222-1. Epub 2016 Jul 28. PubMed PMID: 27468734.
  • Khalid N, Ikram S. Microvascular dysfunction in Takotsubo cardiomyopathy: Prognostic implications. Int J Cardiol. 2015 Dec 15;201:58-9. doi: 10.1016/j.ijcard.2015.08.018. Epub 2015 Aug 2. PubMed PMID: 26288330.
  • Khalid N, Ikram S. Coronary flow assessment in Takotsubo cardiomyopathy with TIMI frame count. Int J Cardiol. 2015 Oct 15;197:208. doi: 10.1016/j.ijcard.2015.06.078. Epub 2015 Jun 30. PubMed PMID: 26142964.
  • Khalid N, Iqbal I, Coram R, Raza T, Fahsah I, Ikram S. Thrombolysis In Myocardial Infarction Frame Count in Takotsubo Cardiomyopathy. Int J Cardiol. 2015 Jul 15;191:107-8. doi: 10.1016/j.ijcard.2015.04.192. Epub 2015 Apr 29. PubMed PMID: 25965614.